Cancer News and Research

Latest Cancer News and Research

Optimum radiation dose on same day as brachytherapy implant can control prostate cancer

Ensuring the optimum radiation dose on the same day as the brachytherapy implant in prostate cancer treatment manages to control the illness in about 95% of the cases. This is the result of research undertaken at the University Hospital of Navarre and published in the latest issue of Brachytherapy, journal of the American Society of Brachytherapy.

23 Jun 2010

Educational comic strips can help young girls make better food choices, improve physical fitness: Study

Lively, educational comic strips, geared to 8- to 10-year-old African-American girls, can help these young viewers make better food choices and improve their physical fitness. That's what happened in a preliminary study, reported several years ago, with 78 Internet-savvy African American girls age 8 to 10. Now, the program's creators hope to repeat the study in a larger test with 400 young volunteers and their parents. The scientists also want to develop a version targeted to Hispanic girls.

23 Jun 2010

Folic acid and vitamin B12 lower homocysteine levels in patients who experience heart attack: JAMA

Patients who had experienced a heart attack and lowered their blood homocysteine levels with folic acid and vitamin B12 supplementation did not have an associated lower risk of heart attack, coronary death or stroke, according to a study in the June 23/30 issue of JAMA. However, the researchers did find that folic acid supplementation did not increase the risk of cancer, which has been speculated.

23 Jun 2010

Misperceptions about 'light,' 'low,' 'mild' cigarettes

Today, new legislation will go into effect surrounding the ban of word descriptors such as "light," "low," and "mild" on all packaging and advertising of existing cigarettes and smokeless products. However, a new survey, sponsored by GlaxoSmithKline (GSK) Consumer Healthcare, shows that many smokers will choose the cigarettes in lighter-colored packaging because they incorrectly believe these cigarettes would be less harmful to their health or make it easier to quit smoking.

23 Jun 2010

Endocrine Society presents Scientific Statement on menopausal hormone therapy at ENDO 2010

The Endocrine Society presented its Scientific Statement on menopausal hormone therapy Monday in San Diego, Calif. at ENDO 2010: The 92nd Annual Meeting & Expo.

23 Jun 2010

Study shows monitoring can be the best treatment for men with prostate cancer of low-risk type

Monitoring can be the best treatment for men with prostate cancer of the low-risk type, according to a study now being published in the Journal of the National Cancer Institute. The lead author is Pär Stattin, a urologist at Umeå University.

23 Jun 2010

Recent objections would eliminate use of routine breast cancer screening mammograms: Authors

The firestorm that followed the November 2009 release of guidelines that would have reduced use of screening mammograms in women aged 40 to 49 highlights challenges for implementing the findings of comparative effectiveness research, according to a new analysis. Meeting such challenges - which may become more common due to increased funding for CER - requires better communication to the public and stakeholders about evidence and its connection to health care quality and efficiency.

23 Jun 2010

Excessive, uncontrolled vascular growth leads to development of cavernomas: Researchers

Benign vascular malformations known as cavernomas can occur in many tissues of the body. These abnormalities are characterized by enlarged, instable and unstructured blood vessels. Cavernomas of medical relevance are primarily those of the brain, which develop approximately in one out of two hundred people. In the brain, such growths often remain unnoticed and are typically found by chance in MRI scans. If they grow larger, they often cause unspecific symptoms such as headaches or dizziness.

23 Jun 2010

First anniversary of Tobacco Control Act: AACR calls for more research to combat tobacco epidemic

The American Association for Cancer Research recognizes the first anniversary of the Family Smoking Prevention and Tobacco Control Act, which was signed into law by President Obama on June 22, 2009.

23 Jun 2010

A*STAR physicist receives prestigious 2010 IEEE Medal for Innovations in Healthcare Technology

Physicist David William Townsend will be honoured with the prestigious 2010 IEEE Medal for Innovations in Healthcare Technology for the design, commercial development and clinical implementation of the PET/CT scanner. Prof Townsend will receive the medal jointly with his co-inventor, engineer Ronald Nutt, on 26 June 2010 at the IEEE Honors Ceremony in Montreal, Quebec, Canada. IEEE is the world's largest professional association advancing technology for humanity.

23 Jun 2010

Resveratrol found in red wine neutralizes toxicity of proteins related to Alzheimer's disease: Research

An organic compound found in red wine - resveratrol - has the ability to neutralize the toxic effects of proteins linked to Alzheimer's disease, according to research led by Rensselaer Professor Peter M. Tessier. The findings, published in the May 28 edition of the Journal of Biological Chemistry, are a step toward understanding the large-scale death of brain cells seen in certain neurodegenerative diseases.

23 Jun 2010

Recent study shows drinking coffee protects against head and neck cancer

Data on the effects of coffee on cancer risk have been mixed. However, results of a recent study add to the brewing evidence that drinking coffee protects against cancer, this time against head and neck cancer.

23 Jun 2010

Researchers identify promising gene therapy for DMD

CureDuchenne, the Orange County non-profit focused on finding a cure for Duchenne muscular dystrophy (DMD) is one step closer to that goal through the work of Dr. Jeff Chamberlain.

23 Jun 2010

Canada and New Zealand charities join international alliance in global fight against bowel cancer

UK charity Beating Bowel Cancer and Bowel Cancer Australia today welcomed the addition of the Colorectal Cancer Association of Canada and Beat Bowel Cancer New Zealand to the bowel cancer international alliance, Bowel Cancer International.

23 Jun 2010

OvaGene Oncology opens new advanced molecular research and clinical laboratory facility

OvaGene Oncology Inc., a biotechnology company specializing in the development and commercialization of personalized DNA-based diagnostics for gynecologic cancer, announced today the opening of its new clinical and research laboratory in Irvine, California. This state-of-the-art facility will serve as the central headquarters for operations, research, and molecular clinical lab testing.

23 Jun 2010

Phase I/II clinical trials show crizotinib reduces lung cancer tumors

Patients with a specific kind of lung cancer may benefit from a Phase III clinical trial offered by the Moores UCSD Cancer Center. The new drug, crizotinib, under development by Pfizer, showed dramatic results in reducing lung cancer tumors in some patients during Phase I and II clinical trials.

23 Jun 2010

Mice treated with XOMA 052 experiences improvement in measures associated with diabetes: Endocrinology

XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, announced the publication of data from a mouse model of diet-induced obesity in the June, 2010 edition of the journal Endocrinology. The data showed that mice treated with XOMA 052 both prophylactically and therapeutically experienced improvement in measures associated with diabetes and cardiovascular disease including reduction in glycosylated hemoglobin levels, improvement in glucose control, improved beta-cell survival and function, and a reduction in total cholesterol without reduction in high density lipoprotein.

23 Jun 2010

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

23 Jun 2010

IMUC signs exclusive licensing agreement with Targepeutics for acquisition of IL-13Ra2 receptor

ImmunoCellular Therapeutics, a clinical-stage biotechnology company focused on developing new immune-based products to treat cancer, today announced it has entered into an exclusive licensing agreement with Targepeutics, Inc. for ImmunoCellular's acquisition of Targepeutics' worldwide intellectual property rights surrounding the IL-13 receptor, alpha 2.

23 Jun 2010

Exposure to chlordecone associated to increased risk of prostate cancer: Researchers

In an article to be published on 21 June 2010 in the Journal of Clinical Oncology, researchers from Inserm (Inserm unit 625 - Research Group on Human and Mammalian Reproduction, University of Rennes 1), the CHU (University Hospital Centre) in Pointe - Pitre (urology department, University of the French West Indies and Guiana) and from the Center for Analytical Research and Technology (University of Li-ge, Belgique), show that exposure to chlordecone (also named Kepone), an organochlorine chemical with well defined estrogenic properties used in the French West Indies until 1993, is associated to a significant increased risk of prostate cancer.

23 Jun 2010

Cancer News and Research

Latest Cancer News and Research

Optimum radiation dose on same day as brachytherapy implant can control prostate cancer

Educational comic strips can help young girls make better food choices, improve physical fitness: Study

Folic acid and vitamin B12 lower homocysteine levels in patients who experience heart attack: JAMA

Misperceptions about 'light,' 'low,' 'mild' cigarettes

Endocrine Society presents Scientific Statement on menopausal hormone therapy at ENDO 2010

Study shows monitoring can be the best treatment for men with prostate cancer of low-risk type

Recent objections would eliminate use of routine breast cancer screening mammograms: Authors

Excessive, uncontrolled vascular growth leads to development of cavernomas: Researchers

First anniversary of Tobacco Control Act: AACR calls for more research to combat tobacco epidemic

A*STAR physicist receives prestigious 2010 IEEE Medal for Innovations in Healthcare Technology

Resveratrol found in red wine neutralizes toxicity of proteins related to Alzheimer's disease: Research

Recent study shows drinking coffee protects against head and neck cancer

Researchers identify promising gene therapy for DMD

Canada and New Zealand charities join international alliance in global fight against bowel cancer

OvaGene Oncology opens new advanced molecular research and clinical laboratory facility

Phase I/II clinical trials show crizotinib reduces lung cancer tumors

Mice treated with XOMA 052 experiences improvement in measures associated with diabetes: Endocrinology

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

IMUC signs exclusive licensing agreement with Targepeutics for acquisition of IL-13Ra2 receptor

Exposure to chlordecone associated to increased risk of prostate cancer: Researchers

Cancer Research - Second Edition eBook

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

Cancer News and Research

Latest Cancer News and Research

Cancer Research - Second Edition eBook

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

Newsletters you may be interested in